SCHEMBL19745586

SCHEMBL19745586

N/C(=N\O)c1ccc(NC(CO)c2ccccc2)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 1/20 0.46
IRAK4 Q9NWZ3 1/20 0.46
RPS6KB1 P23443 4/20 0.39
AURKA O14965 3/20 0.39
KDM4E B2RXH2 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
EGFR P00533 2/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
HCAR3 P49019 3/20 0.37
HCAR2 Q8TDS4 1/20 0.37
F10 P00742 1/20 0.37
CCNT1 O60563 2/20 0.36
CDK9 P50750 2/20 0.36
MAPK1 P28482 2/20 0.36
MAPK13 O15264 1/20 0.36
ROCK2 O75116 1/20 0.36
RPS6KA5 O75582 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19745584 1.00 JAK3 (0.46) JAK3IRAK4RPS6KB1AURKAKDM4E
SCHEMBL19745585 1.00 JAK3 (0.46) JAK3IRAK4RPS6KB1AURKAKDM4E
SCHEMBL6421065 0.75 IDO1 (0.48) JAK3IRAK4KDM4EHTTNPSR1
SCHEMBL14993824 0.73 POLB (0.48) JAK3IRAK4KDM4E
SCHEMBL14993826 0.73 POLB (0.48) JAK3IRAK4KDM4E
SCHEMBL1727057 0.72 HCAR3 (0.43) EGFRHCAR3HCAR2F10
SCHEMBL6417188 0.72 TRPV3 (0.50) JAK3IRAK4KDM4EHTTNPSR1
SCHEMBL19745879 0.72 IRAK4 (0.48) JAK3IRAK4RPS6KB1AURKAKDM4E
SCHEMBL19745878 0.72 IRAK4 (0.48) JAK3IRAK4RPS6KB1AURKAKDM4E
SCHEMBL1727055 0.72 HCAR3 (0.43) EGFRHCAR3HCAR2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3475275-B1 3-ARYL AND HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS MERCK SHARP & DOHME LLC (US) 2024-04-10 EP disclosed
US-11066396-B2 3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors MERCK SHARP & DOHME CORP. (US) 2021-07-20 US disclosed
US-20190185462-A1 3-ARYL- HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONEDEACETYLASE 6 (HDAC6) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2019-06-20 US disclosed
EP-3475275-A1 3-ARYL AND HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS Merck Sharp & Dohme Corp. (US) 2019-05-01 EP disclosed
WO-2017222951-A1 3-ARYL AND HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11066396-B2 3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors HDAC6, HDAC1, HDAC5 JAK3 479/4885IRAK4 2628/4885RPS6KB1 2643/4885
US-20190185462-A1 3-ARYL- HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONEDEACETYLASE 6 (HDAC6) INHIBITORS HDAC6, HDAC1, HDAC5 JAK3 479/4885IRAK4 2628/4885RPS6KB1 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.